FY2025 Earnings Estimate for QIPT Issued By Leede Financial

Key Points

• Leede Financial has raised its FY2025 earnings per share estimate for Quipt Home Medical to ($0.28), up from a previous estimate of ($0.33).
• Quipt Home Medical reported quarterly earnings of ($0.07) per share, missing the consensus estimate of $0.03 by ($0.10).
• Several brokerages have revised their ratings for QIPT, with Benchmark maintaining a "buy" rating but lowering its price target from $6.00 to $4.00.

Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) - Analysts at Leede Financial boosted their FY2025 earnings per share estimates for shares of Quipt Home Medical in a research report issued to clients and investors on Tuesday, August 12th. Leede Financial analyst D. Loe now expects that the company will earn ($0.28) per share for the year, up from their prior estimate of ($0.33). The consensus estimate for Quipt Home Medical's current full-year earnings is ($0.05) per share. Leede Financial also issued estimates for Quipt Home Medical's FY2026 earnings at ($0.04) EPS and FY2027 earnings at $0.09 EPS.

Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last issued its quarterly earnings data on Monday, August 11th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.10). Quipt Home Medical had a negative net margin of 4.30% and a negative return on equity of 9.78%. The company had revenue of $58.30 million for the quarter, compared to the consensus estimate of $80.37 million.

Several other brokerages have also weighed in on QIPT. Benchmark reissued a "buy" rating and issued a $4.00 price objective (down previously from $6.00) on shares of Quipt Home Medical in a report on Wednesday, May 14th. Canaccord Genuity Group reissued a "hold" rating and issued a $1.70 price objective (down previously from $4.00) on shares of Quipt Home Medical in a report on Tuesday, May 13th. Finally, Wall Street Zen downgraded Quipt Home Medical from a "hold" rating to a "sell" rating in a research note on Thursday, May 22nd.

Quipt Home Medical Stock Performance

Shares of Quipt Home Medical stock traded up $0.03 during trading hours on Friday, hitting $2.02. 2,766 shares of the company's stock traded hands, compared to its average volume of 533,516. Quipt Home Medical has a 12-month low of $1.35 and a 12-month high of $3.27. The stock has a market capitalization of $87.92 million, a price-to-earnings ratio of -8.42 and a beta of 0.59. The company has a fifty day simple moving average of $2.01 and a 200-day simple moving average of $2.20. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.15 and a quick ratio of 0.85.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. Kanen Wealth Management LLC grew its holdings in shares of Quipt Home Medical by 108.4% during the first quarter. Kanen Wealth Management LLC now owns 2,969,541 shares of the company's stock worth $6,919,000 after purchasing an additional 1,544,529 shares in the last quarter. Wells Fargo & Company MN lifted its position in Quipt Home Medical by 30.9% in the 4th quarter. Wells Fargo & Company MN now owns 23,851 shares of the company's stock worth $73,000 after buying an additional 5,625 shares during the last quarter. BNP Paribas Financial Markets bought a new stake in Quipt Home Medical in the 4th quarter worth approximately $137,000. Bank of America Corp DE lifted its position in Quipt Home Medical by 13.5% in the 4th quarter. Bank of America Corp DE now owns 81,770 shares of the company's stock worth $249,000 after buying an additional 9,757 shares during the last quarter. Finally, Northern Trust Corp lifted its position in Quipt Home Medical by 2.8% in the 4th quarter. Northern Trust Corp now owns 257,402 shares of the company's stock worth $785,000 after buying an additional 7,095 shares during the last quarter. Institutional investors own 42.85% of the company's stock.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.